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Abstract
Background: Plants provide an alternative source to manage various human disorders due to diverse metabolites.
Euphorbia dracunculoides of family Euphorbiaceae is used by local practitioners in rheumatism, epilepsy, edema,
snake bite, warts and also possesses diuretic and purgative effects. The present study evaluated the antioxidant,
anti-inflammatory and analgesic activities of various extracts of E. dracunculoides. Further, phytochemical constituents of
the leading extracts were also investigated.
Methods: Dry powder of E. dracunculoides was extracted with n-hexane (EDH), acetone (EDA), ethanol (EDE), ethanol +
water (1:1) (EDEW) and methanol (EDM) and screened for phytochemical classes, total phenolic (TPC) and flavonoid
content (TFC). Antioxidant effects of the extracts were manifested by in vitro multidimensional assays. The anti-
inflammatory and analgesic activities of the extracts were evaluated through carrageenan induced paw edema and hot
plate test in rat. In addition, GC-MS analysis of EDH and HPLC-DAD analysis of EDEW was carried out to determine the
presence of active constituents.
Results: Qualitative analysis of various extracts of E. dracunculoides assured the existence of tannins and coumarins
while presence of anthraquinones and anthocyanins was not traced in these extracts. Maximum quantity of TPC and
TFC was recorded in EDEW followed by EDE. EDEW and EDE showed significant antioxidant activities with therapeutic
potential against hydroxyl and phosphomolybdate radicals, β-carotene bleaching assay and in reducing of iron while
moderate to low scavenging abilities were recorded for DPPH, nitric oxide and for iron chelation. During anti-
inflammatory activity after 4 h of drug administration the 300 mg/kg body weight dose of EDH (68.660 ± 10.502 %) and
EDE (51.384 ± 8.623 %) exhibited strong anti-inflammatory activity and reduced the carrageenan-induced paw edema in
rat as compared to standard drug diclofenac sodium (78.823 ± 6.395 %). Treatment of rats with EDH (70.206 ± 5.445 %)
and EDE (56.508 ± 6.363 %) after 90 min showed significant increase in percent latency time in hot plate test
as compared to morphine (63.632 ± 5.449 %) treatment in rat. GC-MS analysis of EDH indicated the presence
of 30 compounds predominantly of steroids and terpenoids. HPLC-DAD analysis against known standards established
the presence of rutin, catechin, caffeic acid and myricetin in EDEW.
Conclusion: Our results suggest that presence of various polyphenolics, terpenoids and steroids render E. dracunculoides
with therapeutic potential for oxidative stress and inflammation related disorders.
Keywords: Euphorbia dracunculoides, Antioxidant, Anti-inflammatory, Analgesic, Terpenoids, Steroids
* Correspondence: majidpharma808@gmail.com; mrkhanqau@yahoo.com
1Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam
University, Islamabad, Pakistan
Full list of author information is available at the end of the article
© 2015 Majid et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Majid et al. BMC Complementary and Alternative Medicine  (2015) 15:349 
DOI 10.1186/s12906-015-0868-0
Background
Medicinal plants play an appealing role in modulation of
several human disorders. Many civilizations and cultures
like Chinese, Ayurvedic, Unani and Hindi has a confirm
belief on these cures to treat their health related issues.
Plants derived chemicals are important source of clinical
agents that have sedative, anti-depressant, antioxidant,
antispasmodic, anxiolytic, anti-inflammatory, immuno-
modulatory, analgesic, anti-pyretic, and cardio protective
activities [1]. This customary herbal medicinal system is
deep rooted in their cultures and habitats and know-
ledge of home remedies is conveyed accordingly to their
descendants as the time goes [2].
During the normal metabolic process human body
produce reactive oxygen species (ROS) and reactive ni-
trogen species (RNS) as byproduct to accomplish the
normal physiological processes. Oxidative stress can be
declared as a root cause for many diseases especially
chronic inflammatory disorders such as rheumatism,
diabetes, carcinomas, mutagenesis, sarcomas, aging and
circulatory disorders [3]. Living cells possess an excellent
defense mechanism to cope with damaging effects of
free radicals and this is made possible by a variety of de-
toxifying enzymes and metabolites inside the body that
scavenge free radicals in a professional way. Among
them superoxide dismutase (SOD), catalase (CAT) and
peroxidase (POD) are the main stream enzymes supported
with scavengers and chelating agents. The indirectly acting
antioxidants are very important in protecting body from
deleterious effects of ROS/RNS. This group comprised
thousands of compounds involved in free radical scaven-
ging and most of them are derived from dietary sources
such as vegetables and fruits.
We are much more endangered by free radicals than
being secured by natural scavenging entities producing
in our body in stressed conditions. Phytochemicals play
a unique role in avoiding hazardous effects of free radi-
cals [4]. Polyphenols are excellent free radical scavengers
and inhibitors of lipid peroxidation. Terpenoids and ste-
roids are useful metabolites for various metabolic disor-
ders. These properties make their role crucial from
therapeutic and pharmacologic point of views.
The trend of finding the pharmacological activities of
the plants of known medicinal uses in folk medicines is
quite much effective than going randomly after it [5, 6].
The genus Euphorbia contributes as the largest amongst
the spurge family with over 2000 species, with awesome
use value in folk Chinese medicinal system used mainly
for skin diseases and edemas [7].
Several species of Euphorbia have been used in local
system of medicine; for the treatment of various ail-
ments. Rhizome of Euphorbia neriifolia and aerial parts
of Euphorbia royleana has been used for the treatment
of anti-inflammatory disorders [8, 9]. In local system of
medicine such as Africa and Australia, Euphorbia hirta
has used as a remedy for various ailments especially in
hypertension and edema. Previous studies have evaluated
E. hirta for antipyretic, analgesic, anti-inflammatory and
diuretic activities [10, 11]. Strong antioxidant activity of
E. macroclada and E. acanthothamnos has been deter-
mined in previous studies [12].
Euphorbia dracunculoides Lam., (Euphorbiaceae) is
distributed in Southwest Asia, North Africa and South
Europe. It is an annual herb and is usually found along
riverbanks, in valleys and roadsides of sandy areas in
Khyber Pakhtunkhwa Province of Pakistan. Fruits are
used to remove warts from skin [13]. Leaves are used in
snake bite and epilepsy [14]. A decoction of whole plant
is applied on body of cattle for lice killing [15]. Euphor-
bia dracunculoides has been used by local practitioners
for its diuretic and purgative properties. Structurally
diversified 19 diterpenoids have been isolated from aerial
parts of E. dracunculoides [16]. Because of similar morph-
ology of the dried aerial parts of E. drancunculoides to
Ruta graveolens, it is sold or used clinically as replacement
of R. graveolens for analgesic and inflammatory disorders;
gout and arthritis [17, 18]. To our knowledge the scientific
validation of E. dracunculoides for the use in inflammation
related disorders has not been reported earlier. For this
purpose we investigated preliminary phytochemical com-
position, antioxidant and anti-inflammatory activities of
various extracts of E. dracunculoides. EDEW showed sig-
nificant antioxidant activity; was subjected to HPLC-DAD
analysis for the presence of flavonoid constituents. EDH
exhibited remarkable analgesic and anti-inflammatory ac-
tivities; was explored for GC-MS analysis.
Methods
Preparation of extract
Plant was recognized by its local name and collected from
the District Lakki Marwat in March 2014. The plant sam-
ple after authentication was deposited (Accession No.
127962) at the Herbarium of Pakistan, Quaid-i-Azam
University, Islamabad, Pakistan. The fully shade dried aer-
ial parts of E. dracunculoides were first powdered followed
by two extraction (36 h) with n-hexane, acetone, ethanol,
ethanol + water (1:1 v/v) and 95 % methanol in 2 : 1 ratio
(v/w). Filtered extracts; EDH, EDA, EDE, EDEW and
EDM were dried under vacuum in a rotary evaporator at
40 °C and stored at 4 °C for in vitro and in vivo
experiments.
Phytochemical analysis
Different qualitative tests were employed to identify the
phytochemical classes present in various extract of the
plant E. dracunculoides.
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Assessment of phenols
For the presence of phenols previously reported method-
ology was followed [19]. Each sample (1 mg) was sus-
pended in 2 ml of distilled water containing 10 % ferric
chloride. The confirmation sign for the presence of phe-
nol was the development of blue or green color.
Assessment of flavonoids
Protocol of Trease and Evans [20] was followed to estab-
lish the presence of flavonoids in each sample. Briefly,
1 mg of each sample was allowed to react with 1 ml of
2 N sodium hydroxide and appearance of yellow color
was considered as the confirmation sign of flavonoid
presence.
Assessment of coumarins
An aliquot of each sample (1 mg/ml) was mixed with
1 ml of 10 % sodium hydroxide. Appearance of yellow
color formation in the test tube was the proof of couma-
rins presence in test sample [19].
Assessment of saponins
Each sample (2 mg) was suspended in 2 ml of distilled
water and vigorously shaken. The formation of a soapy
layer of almost 1–2 cm was the indication of saponins
presence [19].
Assessment of tannins
Confirmative sign of tannins was the development of
dark blue or greenish black color on the mixing of 1 mg
of each sample and 2 ml of 5 % ferric chloride [20].
Assessment of terpenoids
Each sample 0.5 mg was mixed with 2 ml of chloroform
and 2 ml of concentrated sulphuric acid. The appearance
of a red brown colored layer in the middle of two layers
confirmed the existence of terpenoids [20].
Assessment of anthraquinone
Development of red color was considered as indication
for the presence of anthraquinone after mixing of 1 mg
of each sample with 2 ml of diluted 2 % hydrochloric
acid [19].
Assessment of anthocyanin and betacyanin
Each sample (1 mg) was boiled for 10 min in 2 ml of
1 N sodium hydroxide. Formation of bluish green color
was the sign of anthocyanin and yellow color formation
of betacyanin presence [20].
Assessment of alkaloids
An amount of 2 mg of each sample was mixed with con-
centrated sulphuric acid. The reaction mixture was
allowed to react with Mayer’s reagent. Appearance of
green color or formation of white precipitates was the
symbol of alkaloid presence [20].
Quantitative analysis
Total phenolic as well as flavonoid contents were quan-
tified by the following narrated procedures.
Total phenolic contents (TPC)
To determine the total phenolic content in each sample
spectrophotometric method already reported was
followed [21]. Briefly, 1 ml of each sample (1 mg/ml)
was mixed with 9 ml of distilled water and I ml of Folin-
Ciocalteu reagent. The mixture obtained was mixed
rigorously for 5 min and 10 ml of 7 % Na2CO3 was
added to the mixture. By the addition of distilled water
the final volume of mixture was made to 25 ml and was
incubated at room temperature for 90 min. Optical
density was ensured at wavelength of 750 nm in tripli-
cate for each sample. By using gallic acid as standard the
estimation of TPC was carried out as mg of gallic acid
equivalents (GAE) per gram of dry extract/fraction.
Total flavonoid content (TFC)
To estimate the TFC in the test samples, 0.3 ml of each
sample was mixed with 0.15 ml of 0.5 M NaNO2
followed by the addition of 0.1 ml of 0.3 M AlCl3.6H2O,
and 3.4 ml of 30 % methanol [22]. An aliquot of 1 ml of
1 M NaOH was added to it after a lapse of 5 min. The
optical density of the reaction mixture was recorded at
506 nm wavelength against the reagent blank. Total fla-
vonoid content as mg rutin equivalents per gram of dry
extract/fraction was estimated while using the calibra-
tion curve of rutin.
Gas chromatography-Mass spectrometry (GC-MS) analysis
EDH was analyzed for the presence of active constitu-
ents on “Thermo GC-Trace Ultra Ver; 5.0” gas chro-
matograph coupled with a “Thermo MS DSQ II” for
mass determination. Components were separated on a
“ZB 5-MS Capillary Standard Non-polar Column” with
60 m length having 0.25 μm film thickness. During the
experiment the temperature was raised from 70 to 260 °C
at a rate of 6 °C/min. The flow rate of the carrier gas;
helium was 1 ml/min while injection volume of the sam-
ples was 1 μl. The identification of chemical constituents
was based on comparison of their relative retention times
and mass spectra with those obtained from authentic sam-
ple and/or the NIST/NBS and Wiley libraries spectra [23].
High performance liquid chromatography (HPLC) analysis
On account of significant antioxidant activity for most
of the in vitro assays the EDEW extract was selected for
HPLC-DAD analysis. HPLC analysis of EDEW was
carried out by using HPLC-DAD (Agilent Germany)
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equipment using Sorbex RXC8 (Agilent USA) analytical
column with 5 μm particle size and 25 ml capacity. Mo-
bile phase was consisted of eluent A, (acetonitrile-
methanol-water-acetic acid /5: 10: 85: 1) and eluent B
(acetonitrile-methanol-acetic acid/40: 60: 1). The gradi-
ent (A: B) utilized was the following: 0–20 min (0 to
50 % B), 20–25 min (50 to 100 % B), and then isocratic
100 % B (25–40 min) at flow rate of 1 ml/min. The in-
jection volume of the sample was 20 μl. Before the injec-
tion samples were filtered through 0.45 μm membrane
filter. Among the standards rutin and gallic acid were
analyzed at 257 nm, catechin at 279 nm, caffeic acid at
325 nm and quercetin, myricetin, kampferol were ana-
lyzed at 368 nm [24]. Each time the column was recon-
ditioned for 10 min before the next analysis. All samples
were assayed in triplicates. Quantification was carried
out by the integration of the peak using the external
standard method. All chromatographic operations were
carried out at an ambient temperature.
In vitro antioxidant assays
The in vitro antioxidant assays were carried out by pre-
paring the plant samples (1 mg/ml) in 95 % methanol
and then making its serial dilutions. The specific proto-
col was followed for finding specific scavenging activities
of the plant samples.
DPPH (1, 1-diphenyl-2-picryl-hydrazyl) radical scavenging
assay
The DPPH scavenging capabilities of deleterious effects
of free radical were determined by following the meth-
odology of [25]. An amount of 24 mg of DPPH was dis-
solved in 100 ml methanol and the stock solution was
kept at 20 °C temperature for further use. The optical
density of DPPH was optimized at 0.908 (±0.02) at
517 nm by diluting the pre made DPPH stock solution
with methanol. An aliquot of 3 ml of DPPH was mixed
with 100 ml plant samples with different concentrations
(25–250 μg/ml). Following continuous stirring the test
tubes were incubated for 15 min at room temperature.
Optical density was recorded at wavelength of 517 nm.
Ascorbic acid was used as standard to compare the anti-
oxidant activity. Antioxidant capacity was determined by
the following equation:




Hydroxyl radical scavenging assay
The power of scavenging hydroxyl free radicals refers to
the antioxidant potential of plant samples using method-
ology practiced by [26]. This technique involved the
mixing of 500 μl of 2-deoxyribose (2.8 mM) prepared in
50 mM phosphate buffer and its pH was maintained at
7.4. The reaction mixture was prepared by addition of
100 μl of 0.1 M EDTA, 200 μl of ferric chloride (100 mM)
and 100 μl of 200 mM H2O2 and 100 μl of plant sample.
The initiation of reaction was brought by the introduc-
tion of 100 μl of ascorbic acid (300 mM) and incubated
for 1 h at 37 °C. Then 1 ml of 2.8 % trichloroacetic acid
and 1 ml of 1 % w/v thiobarbituric acid prepared in
50 mM NaOH were added to the reaction mixture. The
whole recipe was heated in water bath for 15 min. After
cooling to room temperature the absorbance of the reac-
tion mixture was recorded at 532 nm. The hydroxyl rad-
ical scavenging activity was analyzed by the following
formula:




Nitric oxide scavenging assay
The method of Bhaskar and Balakrishnan [27] was used
to assess the nitric oxide scavenging potential of the
plant samples. The Griess reagent was prepared by add-
ing equimolar quantity of 0.1 % napthylenediamine in
distilled water and 1 % of sulphanilamide in 5 % phos-
phoric acid. A volume of 100 μl of sample was added to
100 μl of sodium nitroprusside (10 mM) being prepared
in saline phosphate buffer. An aliquot of 1 ml of the
Griess reagent was added to the reaction mixture. After
incubation at room temperature for 3 h the optical dens-
ity of the reaction mixture was noted spectrophotomet-
rically at 546 nm using ascorbate as a positive control.
Following formula was used for determining the per-
centage inhibition of nitric oxide radical formation.





The iron (II) binding capability at multiple sites confers
the antioxidant potential of plant samples [28]. The
plant sample with its serial dilutions was prepared in
methanol and 200 μl of each dilution was mixed with
900 μl of methanol and 100 μl FeCl2.2H2O (2.0 mM)
and incubated for 5 min. The reaction was initiated by
introducing 400 μl of ferrozine (5.0 mM). After incu-
bation for 10 min the optical density was recorded at
562 nm using EDTA as standard in comparison. The
chelating power was determined by the following
formula:
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Inhibition ability of β-carotene bleaching was recorded
by the method of [29]. The reagent was prepared by dis-
solving 2 mg of β-carotene in 10 ml of chloroform
followed by addition of 200 mg of Tween 80 and 20 mg
of linoleic acid. After evaporation of chloroform, 50 ml
of distilled water was added to the reaction mixture and
vigorously vortexed to get a uniform emulsion of β-
carotene linoleate. In freshly prepared 250 μl of emul-
sion, 30 μl of plant sample was added and optical density
was measured at 470 nm at 0 h. Then after keeping the
reaction mixture at 45 °C for 2 h the final optical density
was again recorded. Catechin was served as standard in
this assay and % inhibition of β-carotene was determined
by the formula:
% inhibition ¼ AA 120ð Þ–AC 120ð Þ
 
= AC 0ð Þ–AA 120ð Þ
    100
Where AA (120) is the absorbance of the antioxidant
at t = 120 min, AC (120) is the absorbance of the control
at t = 120 min, and AC (0) is the absorbance of the con-
trol at t = 0 min.
Reducing power assay
Reducing power of various extracts was estimated by the
method of [30, 31]. Briefly, 2 ml of plant extract was
mixed with 2 ml of 0.2 M phosphate buffer (pH 6.6) and
2 ml of potassium ferricyanide (10 mg/l) and the reac-
tion mixture was incubated at 50 °C for 20 min. After
addition of 2 ml of trichloroacetic acid (100 mg/l) in the
reaction mixture, 2 ml was of it was diluted with 2 ml of
distilled water and 0.4 ml of FeCl3 (0.1 %). Optical dens-
ity of the reaction mixture was measured at 700 nm after
10 min of incubation. Gallic acid was used as standard.
Phosphomolybedenum assay
The methodology of [31] was used to assess the antioxi-
dant capabilities of the plant sample. Accordingly, 0.1 ml
of the plant sample was mixed with 1 ml of the reagent
solution (prepared by adding 28 mM Na3PO4 and 0.6 M
H2SO4 with that of 4 mM ammonium molybdate). After
incubation at 95 °C in a water bath for 90 min the reac-
tion mixture was cooled down to room temperature and
optical density was recorded at 765 nm. Ascorbic acid
served as standard in this assay.
Anti-inflammatory activity
Protocol of [32] was followed to estimate the anti-
inflammatory activity of extracts by carrageenan-induced
paw edema in rat. Sprague-Dawley rats (six weeks old)
weighing about 150–200 g were randomly divided into
six groups containing 6 rats in each group. Rats had free
access to the laboratory feed and water. National insti-
tute of health (NIH) guidelines were strictly carried out
using test animals for experimentation. Ethical Commit-
tee of Quaid-i-Azam University Islamabad approved the
study protocol (Bch#0267) for the animal care and ex-
perimentation. Group I was negative control and re-
ceived DMSO, Group II orally received 10 mg/kg of
drug diclofenac sodium (1:1 W/V DMSO). Group III to
Group VII were given 300 mg/kg dose of EDH, EDA,
EDE, EDEW and EDM respectively. To develop the paw
edema, 1 ml/kg body weight of carrageenan solution
(0.9 % w/v; saline) was injected in the right paw of each
rat after 1 h of the administration of plant sample. Paw
volume was measured plethysmographically at 0, 1st,
2nd, 3rd and 4th h after carrageenan injection and the
following formulae for calculating percent inhibition of
edema were used;
EV ¼ PVA−PVI
Where, EV = Edema volume, PVI = Paw volume before
carrageenan administration (i.e. initial paw volume) and,
PVA = Paw volume after carrageenan administration.
Percent inhibition ¼ EVc – EVtð Þ
EVcð Þ  100
 
:
EVc = Edema volume of control animals, EVt = Edema
volume of test sample animals.
Analgesic activity
The procedure described by [33], was followed to per-
form this test. Sprague-Dawley rats of either sex (n = 6)
weighing 180–220 g were used. Animals were subjected
to pre-testing on a hot plate analgesimeter (Harvard ap-
paratus Ltd., UK) maintained at 55 ± 0.1 oC. Animals
having latency time greater than 15 s on hot plate during
pre-testing were excluded. Animals were divided ran-
domly into 7 groups, each consisting of six rats. Group I
was negative control and received 2 ml/kg p.o. DMSO,
Group II received 10 mg/kg i.p. of the standard drug
morphine sulphate. Group III to Group VII were given
300 mg/kg p.o. dose of EDH, EDA, EDE, EDEW and
EDM respectively. The latency time was recorded for
each group at 0, 30, 60 and 90 min following drug ad-
ministration. In order to prevent the tissue damage the
cut off time of 30 s was set for all animals. Percent anal-
gesia was calculated using the following formula.
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% Analgesia ¼ Test latency – control latencyð Þ
Cut off time−control latencyð Þ  100
 
Statistical analysis
Data obtained in this study was presented as mean ± SD.
One way analysis of variance was performed to deter-
mine the variability among groups by Statistix 8.1.
GraphPad Prim 5 was used to determine the correlation
of IC50 values of antioxidant assays with TPC and TFC by
Pearson’s correlation coefficient. Significant differences
among groups were calculated by Tukey’s multiple com-
parison tests. Statistical significance was set at P > 0.05.
Results
Extraction yield, total phenolic and flavonoid content
By using 100 g of dry powder of E. dracunculoides for
extraction, the maximum yield 5462 mg powder was ob-
tained for EDEW followed by 1703 mg (EDM), 1340 mg
(EDA), 724 mg (EDE) and 592 mg (EDH). On the
basis of standard regression lines for gallic acid (y =
0.0103x + 0.1875; R2 = 0.9978) and rutin (y = 0.00028x +
0.497; R2 = 0.998), the equivalents of TPC and TFC were
calculated (Table 1). EDEW showed maximum quantity of
TPC (17.35 ± 0.62 mg GAE/g dry sample) followed by EDE
(16.41 ± 0.54 mg GAE/g dry sample), EDM (14.11 ±
0.37 mg GAE/g dry sample), EDA (10.62 ± 0.33 mg GAE/g
dry sample) and EDH (8.21 ± 0.49 mg GAE/g dry sample).
Flavonoids were found to be rich in EDEW (7.57 ± 0.42 mg
RE/g dry sample) followed by EDE (6.77 ± 0.31 mg RE/g
dry sample), EDM (4.84 ± 0.29 mg RE/g dry sample), EDA
(4.52 ± 0.37 mg RE/g dry sample) and EDA (4.18 ± 0.25 mg
RE/g dry sample).
Phytochemical classes
The results of phytochemical analysis of all the extracts
of E. dracunculoides are listed in Table 2. Qualitative
analysis of E. dracunculoides ensured the presence of
tannins, phenols, flavonoids and coumarins in all ex-
tracts of E. dracunculoides except coumarins were ab-
sent in EDH. Presence of anthraquinones was not
recorded in all the extracts. EDEW contained the
maximum phytochemical classes and EDA showed the
least number of existent phytochemical classes.
GC-MS analysis of n-hexane extract
The n-hexane extract of E. dracunculoides was selected
for GC-MS analysis due to its significant analgesic and
anti-inflammatory activities. GC-MS analysis indicated
that EDH contained 30 chemical constituents eluted be-
tween 6.36 and 40.10 min (Fig. 1). The identification of
chemical constituents was based on comparison of their
relative retention times and mass spectra with those ob-
tained from authentic sample and/or the NIST/NBS and
Wiley libraries spectra (Table 3). Of these 30 chemical
constituents, there were 7 terpenoides (13.25 % on the
basis of peak area), 4 lactones (2.12 %), 3 steroids
(2.59 %), 3 phenols (1.60 %), 2 hetrocycles (73.91 %), 1
fatty acid (2.63 %), 1 ester (1.30 %), 1 carboxylic acid
(0.58 %), 1 lactam (0.51 %), 1 nitrile (0.40 %), 1 alkyne
(0.36 %), 1 hydrazone (0.19 %), 1 terpene (0.18 %), 1 al-
dehyde (0.14 %), 1 ketone (0.13 %) and 1 amino acid
(0.1 %) in EDH.
HPLC-DAD analysis of ethanol + water extract
HPLC-DAD profile of EDEW was illustrated in Fig. 2.
EDEW showed the existence of rutin, catechin, caffeic
Table 1 Extraction yield, total phenolic and flavonoid contents of E. dracunculoides
Extract Yield (mg/100 g powder) Total phenolic content (mg gallic acid
equivalent/ g dry sample)
Total flavonoid content
(mg rutin equivalent/ g dry sample)
EDH 592 8.21 ± 0.49e 4.18 ± 0.25e
EDA 1,340 10.62 ± 0.33d 4.52 ± 0.37d
EDE 724 16.41 ± 0.54b 6.77 ± 0.31b
EDEW 5,462 17.35 ± 0.62a 7.57 ± 0.42a
EDM 1,703 14.11 ± 0.37c 4.84 ± 0.29c
EDH E. dracunculoides n-hexane extract, EDA E. dracunculoides aqueous extract, EDE E. dracunculoides ethyl acetate, EDEW E. dracunculoides ethyl acetate + water
extract, EDM E. dracunculoides methanol extract. Each value is represented as mean ± SD (n = 3). Means with different superscript (a-e) letters in the column are
significantly (P < 0.05) different from one another
Table 2 Phytochemical analysis of E. dracunculoides
Phytochemical EDH EDA EDE EDEW EDM
Terpenoids ++ - - + -
Coumarins - + ++ +++ +++
Flavonoids + + +++ +++ ++
Tannins + ++ ++ +++ +++
Anthraquinones - - - - -
Phenols + + +++ +++ ++
Alkaloids + - - ++ ++
Saponins - - - ++ -
Betacyanin - - + ++ ++
(+) present, (-) absent, (++) moderate concentration, (+++) abundant concentration
EDH E. dracunculoides n-hexane extract, EDA E. dracunculoides aqueous extract,
EDE E. dracunculoides ethyl acetate, EDEW E. dracunculoides ethyl acetate +
water extract, EDM E. dracunculoides methanol extract
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acid and myricetin. Rutin showed maximum quantity
(65.8 ± 2.2 μg/mg dry extract) followed by catechin (15.3 ±
1.2 μg/mg dry extract), caffeic acid (8.5 ± 0.75 μg/mg dry
extract) and myricetin (4.54 ± 0.35 μg/mg dry extract) as
demonstrated in Table 4.
In vitro antioxidant activities
DPPH radical scavenging activity
Moderate to low scavenging activity for DPPH was ex-
hibited by all the extracts of E. dracunculoides (Table 5).
Minimum IC50 values were exhibited by EDEW (144.7 ±
3.4 μg/ml) followed by EDE (263.6 ± 3.7 μg/ml) and
EDM (351.3 ± 4.5 μg/ml) while EDA and EDH showed
the higher IC50 values (> 1000 μg/ml). Overall, order of
IC50 of EDEW < EDE < EDM < EDA < EDH was ob-
served. The DPPH radical scavenging activity of extract/
fractions showed significant correlation with TPC (R2 =
0.9028, P < 0.01) and non-significant with TFC (R2 =
0.5687, P > 0.05, Table 6). All the extracts showed the
higher IC50 values than ascorbic acid (26.65 ± 2.4 μg/ml).
However, concentration dependent activity was recorded
for all the extracts.
Hydroxyl radical (•OH) scavenging assay
All the extracts of E. dracunculoides scavenged •OH rad-
icals and prevented 2-deoxyribose breakdown (Table 5).
A concentration-dependent pattern was observed for hy-
droxyl radical scavenging activity. Lowest IC50 values
were recorded for EDEW (78.02 ± 1.21 μg/ml) followed by
EDE (121.70 ± 2.05 μg/ml), EDM (142.43 ± 2.51 μg/ml),
EDA (202.20 ± 3.4 μg/ml) and EDA (297.12 ± 3.22 μg/ml).
IC50 values of EDH, EDA, EDE, EDEW and EDM were
significantly higher from rutin (80.74 ± 2.25 μg/ml) and
gallic acid (45.97 ± 1.92 μg/ml). Significant correlation of
IC50 values of hydroxyl radical scavenging was determined
for TPC (R2 = 0.9505, P < 0.01) as well as for TFC (R2 =
0.7224, P <0.05) (Table 6).
Nitric oxide (NO−) scavenging assay
In the present study, moderate level of nitric oxide scaven-
ging activity was observed for all the extracts with IC50
values for EDEW (317.8 ± 3.35 μg/ml), EDE (366.81 ±
3.12 μg/ml) and EDM (405.01 ± 3.57 μg/ml) as compared
to standard ascorbic acid (244.45 ± 2.35 μg/ml). IC50
values for other extracts were 583.4 ± 3.65 μg/ml and
756.31 ± 4.23 μg/ml for EDA and EDH, respectively
(Table 5). IC50 values obtained for nitric oxide scavenging
activity exhibited a significant correlation with TPC (R2 =
0.9638, P <0.01) and TFC (R2 = 0.6822, P <0.05) (Table 6).
Iron chelating activity
Iron chelating activity (IC50 values) of E. dracunculoides
extracts are given in Table 5. In current study, the best
IC50 values for iron chelation were exhibited by EDE
(279.51 ± 2.57 μg/ml) while the least by EDH (616.57 ±
3.3 μg/ml). IC50 value for other extracts was; EDEW
(331.46 ± 2.42 μg/ml), EDM (446.3 ± 3.52 μg/ml) and
EDA (531.43 ± 2.94 μg/ml). IC50 of standard EDTA was
189.85 ± 1.53 μg/ml (Table 5). Significant correlation
(R2 = 0.9361, P < 0.01) of IC50 values was observed
with TFC (R2 = 0.9361, P < 0.01) and for TPC (R2 =
0.8232, P < 0.05) (Table 6 ).
β-Carotene scavenging activity
Ethanol + water extract of E. dracunculoides (EDEW)
showed the lowest IC50 value (100.40 ± 1.8 μg/ml) as
Fig. 1 GC-MS analysis of n-hexane extract of E. dracunculoides
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compared to other extracts viz. EDE (120.53 ± 2.52 μg/
ml), EDM (210.23 ± 3.41 μg/ml) and EDA (181.10 ±
1.9 μg/ml). However, the maximum IC50 was shown by
EDH (244.06 ± 3.8 μg/ml) as compared to the standard
catechin (78.57 ± 2.15 μg/ml) shown in Table 5. The con-
centration dependent inhibition in β-carotene bleaching
power pattern was observed for all the extracts. The
assay showed significant correlation of IC50 with both
TPC (R2 = 0.7579, P < 0.05) and TFC (R2 = 0.8965, P < 0.01)
as shown in Table 6.
Reducing power assay
Ethanol + water extract (EDEW) showed the highest re-
ducing power with 792.59 mg ascorbic acid equivalent/g
sample measured at 250 μg/ml of extract followed by
EDE (777.77 mg ascorbic acid equivalents/g sample),
EDM (770.37 mg ascorbic acid equivalents/g sample),
EDA (711.11 mg ascorbic acid equivalents/g sample) and
EDH (688.88 mg ascorbic acid equivalents/g sample) as
shown in Fig. 3. There was recorded a significant correl-
ation between the reducing power and with both TPC
(R2 = 0.9812, P < 0.01) and TFC (R2 = 0.7349, P < 0.05)
shown in Table 6.
Total antioxidant capacity (phosphomolybdenum assay)
Total antioxidant capacity of various extracts was deter-
mined by phosphomolybdate method and expressed as
equivalents of ascorbic acid (mg/g of extract) as shown
in Fig. 4. Total antioxidant capacity was found to de-
crease in the order, EDEW > EDE > EDM > EDA > EDH.
All the samples exhibited an increase in antioxidant cap-
acity with increase in concentration. The assay showed
significant correlation with TPC (R2 = 0.7429, P < 0.05)
and TFC (R2 = 0.893, P < 0.01) as shown in Table 6.
Anti-inflammatory activity of E. dracunculoides
The results of carrageenan-induced rat paw edema are
summarized in Table 7. EDH, EDA, EDE, EDEW and
EDM of E. dracunculoides were tested for their anti-
inflammatory effects. The results obtained indicated that
EDH possessed significant (P < 0.05) anti-inflammatory
activity in rats followed by EDE and EDEW. The EDH at
the test dose i.e. 300 mg/kg body weight reduced the
carrageenan-induced edema up to 68.660 ± 10.502 %
whereas the standard drug diclofenac sodium showed
78.823 ± 6.395 % of edema inhibition after 4 h of carra-
geenan injection. Similarly EDE and EDEW showed
51.384 ± 8.623 % and 46.302 ± 8.975 % inhibition of edema
formation after 4 h of carrageenan administration.
Analgesic activity of E. dracunculoides
In this assay E. dracunculoides extracts; EDH, EDA,
EDE, EDEW and EDM were evaluated in rats for their
analgesic potential in hot plate test (Table 8). All the ex-
tracts showed increase in the percent latency period with
the maximum was recorded with 74.309 ± 5.864 % for
EDH as compared to 78.889 ± 5.853 % with morphine
after 60 min of drug administration. The EDE and EDM
also exhibited more than 50 % of analgesia. The extracts
and the standard drug showed less analgesia after
90 min of drug administration except the EDA and
Table 3 GC-MS analysis of EDH
S. No Compound name Type
1 O,N-Permethylated N-Acetyllysine Amino acid
2 Phenol, 2-Methyl-5-(1-Methylethyl)- Phenol
3 2,4-Decadienal, (E,E)- (Cas) Aldehyde






8 2-Pentadecanone, 6,10,14-trimethyl- Terpenoid
9 (E,E)-Farnesyl Acetone Terpenoid
10 Hexadecanoic acid, methyl ester (CAS) Terpenoid
11 Hexadecanoic acid (CAS) Fatty acid
12 Hexadecanoic acid, ethyl ester Terpenoid
13 9,12,15-Octadecatrienoic acid, methyl ester,
(Z,Z,Z)-(CAS)
Terpenoid



























27 1-Heneicosyl formate Terpenoid
28 2-Methoxy-6-hydroxy-1,3-dicyanoazulene Nitrile
29 Xanthinin Lactone
30 Stigmasta-5,22-dien-3-ol, (3á,22E)- (CAS) Steroid
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EDEW where more analgesia was recorded after 90 min
of drug administration.
Discussion
The role of medicinal plants in curing diseases is in-
creasing due to the presence of versatile compounds that
have the ability to cure a variety of diseases and helping
physicians to cope with increasing ratio of ailments these
days [34]. Plants are rich in variety of compounds with
different polarities [35]. Maximum yield was obtained in
EDEW followed by EDM and the minimum yield was
Fig. 2 HPLC-DAD profile of E. dracunculoides ethanol + water extract (EDEW) at different wavelengths. Signal 1: 257λ, Signal 2:279λ, Signal 3: 325λ,
Signal 4; 368λ.Conditions: Mobile Phase A-ACN: MEOH: H2O: AA:: 5:10:85:1, Mobile phase B-ACN: MEOH: AA:: 40:60:1, Injection volume 20 μL, Flow
rate 1 ml/min, Agilent RP-C8
Table 4 HPLC-DAD results for EDEW of E. dracunculoides
Flavonoid/Phenolics Signal wavelength Quantity (μg/mg dry extract)
Rutin 257 65.8 ± 2.2
Catechin 279 15.3 ± 1.2
Caffeic acid 325 8.5 ± 0.75
Myricetin 368 4.54 ± 0.35
EDEW ethanol + water extract. Each value is represented as mean ± SD (n = 3)
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recorded in EDE following the rule that polar solvents
dissolve more compounds in comparison to that of non-
polar in short time at room temperature [36]. Present
studies are in agreement to the concept of polarity based
extraction with the experiment run by [37] on Maytenus
royleanus leaves and [38] evaluating Rumex hastatus
roots.
Preliminary qualitative phytochemical screening gives
a clue for the medicinal aptitude of the herb. In the con-
ducted study bioactive components that impart biologic-
ally active nature to the plant were screened and results
ensured the presence of terpenoids, coumarins, flavo-
noids, tannins, phenols, alkaloids, saponins, and betacya-
nin. These variant compounds ranging from low polarity
to high polarity were extracted in their respective
solvents.
The EDH was analyzed through GC-MS and it was
found to contain 30 chemical constituents eluted be-
tween 6.36 and 40.10 min. Maximum proportion was
contributed by terpenoids followed by lactones, steroids,
phenols and heterocycles. GC-MS analyses of EDH vali-
dated the concept of polarity based extraction as the
most of the compounds identified were of non-polar
nature.
In the present study through HPLC analysis of EDEW
presence of four compounds; rutin, catechin, caffeic acid
and quercetin was evaluated. Rutin was present in max-
imum amount (65.8 ± 2.2 μg/mg dry extract) followed by
catechin (15.3 ± 1.2 μg/mg dry extract). Rutin is a known
and well reputed secondary metabolite of plants with ad-
mirable hepatoprotective, anti-inflammatory and antioxi-
dant activities [39]. Another well-known polyphenolic
compound, catechin has good antioxidant potential and
provides a reliable defense wall against free radicals.
Catechin provides protection against neurological disor-
ders, inflammation and apoptosis. The admiring amount
of standard antioxidant phenolic compounds in EDEW
Table 5 IC50 values of different antioxidant activities of E. dracunculoides extracts
IC50(μg/ml)
Plant sample DPPH scavenging Hydroxyl scavenging Nitric Oxide β-Carotene Iron chelating
EDH >1000 297.12 ± 3.22a 756.31 ± 4.23a 244.06 ± 3.81a 616.57 ± 3.33a
EDA >1000 202.20 ± 3.41b 583.40 ± 3.65b 181.10 ± 1.93c 531.43 ± 2.94b
EDE 263.61 ± 3.71b 121.70 ± 2.05c 366.81 ± 3.12d 120.53 ± 2.52d 279.51 ± 2.57e
EDEW 144.71 ± 3.44c 78.02 ± 1.21d 317.80 ± 3.35e 100.40 ± 1.81e 331.46 ± 2.42d
EDM 351.33 ± 4.54a 142.43 ± 2.51c 405.01 ± 3.57c 210.23 ± 3.41b 446.3 ± 3.52c
Rutin - 80.74 ± 2.25d - - -
AA 26.65 ± 2.41d - 244.45 ± 2.35f - -
Gallic acid - 45.97 ± 1.92e - - -
EDTA - - - - 189.85 ± 1.53f
Catechin - - - 78.57 ± 2.15f -
EDH E. dracunculoides n-hexane extract, EDA E. dracunculoides aqueous extract, EDE E. dracunculoides ethyl acetate, EDEW E. dracunculoides ethyl acetate + water
extract, EDM E. dracunculoides methanol extract
Values are presented as means ± SD (n = 3). Means with different superscript (a-f) letters in the column are significantly (P < 0.01) different from one another
Table 6 Correlation of IC50 values of different antioxidant
activities of E. dracunculoides with total phenolic and total
flavonoid contents
Antioxidant Activity Correlation R2
TFC TPC
DPPH radical scavenging activity 0.9028** 0.5687
Hydroxyl radical scavenging activity 0.9505** 0.7224*
Iron chelating assay 0.9361** 0.8232*
Nitric Oxide radical scavenging Activity 0.9638** 0.6822*
β - carotene bleaching scavenging activity 0.7579* 0.8965**
Phosphomolybdenum assay 0.7429* 0.893**
Reducing power assay 0.9812** 0.7349*
Column with different superscripts are significantly different *, **, indicate P < 0.05,
P < 0.01. TFC total flavonoid content, TPC total phenolic content
Fig. 3 Reducing power activity of different concentrations of
Euphobia dracunculoids extracts
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is the justification of raised antioxidant potential of this
extract. Significant correlation between TPC and TFC
with that of antioxidant assays also validates the HPLC
results.
Natural antioxidants have attained worth reputation in
treating several diseases and have raised the value of folk
herbal medicines in the modern era. The ability of
DPPH radical scavenging is considered as a milestone
while assessing the antioxidant aptitude of a crude plant
extract or an isolated pure compound. It is a very short
timed assay for appraising the antioxidant abilities and
has worth economic values [40]. In this study EDEW
showed the maximum scavenging activity with lowest
IC50 value, followed by EDE < EDM< EDA < EDH. Greater
quantity of phenolics and flavonoids extracted in EDEW
might exhibit good scavenging abilities due to donation of
electron or hydrogen to stabilize DPPH free radicals. None
of the five extracts showed IC50 below ascorbic acid used
as standard. Though [41] and [42] used different tech-
niques for extraction yet our results are consolidating their
findings. The results reported in this study indicated a
good correlation with the TFC while non-significant cor-
relation was recorded with TPC. The strong correlation of
IC50 values with TFC might be attributed by the presence
of active flavonoids such as myricetin, rutin, caffeic acid
and catechin.
Antioxidant potential of a plant crude extract or com-
pound can also be estimated by its ability to oxidize
linoleic acid. β-carotene is a fat soluble hydrocarbon
with yellowish orange color. Linoleic acid hydroperox-
ides on reaction with β-carotene bleaches its color. This
is due to the fact that β-carotene forms a complex with
linoleic acid and oxidizes it. This consumption of β-
carotene causes the reduction of bright yellow color to
light milky color. Now the presence of an antioxidant in
the reaction mixture checks the consumption of β-
carotene by acting on linoleic acid free radicals. As the
β-carotene is released from the complex between it and
linoleic acid, the yellow color of the reaction mixture is
regained. Hence stronger the antioxidant present in the
reaction mixture brighter will be the color and higher
will be its optical density [43]. In the present study,
EDEW and EDE showed the best activity with lower
IC50 values. Significantly good correlation of IC50 values
was observed with TPC (P < 0.01) and TFC (P < 0.05)
Fig. 4 Total antioxidant activity of different concentrations of
Euphobia dracunculoids extracts
Table 7 Effect of E. dracunculoides on carrageenan-induced paw edema in rat
Treatment
mg/kg
Edema volume (ml)/ Percent edema inhibition
0 h 1 h 2 h 3 h 4 h
DMSO (2 ml) 0.506 ± 0.046 0.776 ± 0.045 0.710 ± 0.021 0.671 ± 0.017 0.600 ± 0.021
DIC (10) 0.551 ± 0.056 0.706 ± 0.056 0.640 ± 0.049 0.613 ± 0.049 0.586 ± 0.056
42.862 ± 5.614ab 56.903 ± 8.443ab 69.975 ± 5.730a 78.823 ± 6.395a
EDH (300) 0.548 ± 0.022 0.685 ± 0.033 0.630 ± 0.021 0.615 ± 0.018 0.600 ± 0.023
49.652 ± 7.649a 60.171 ± 3.690a 67.524 ± 8.004a 68.660 ± 10.502a
EDA (300) 0.548 ± 0.035 0.751 ± 0.027 0.696 ± 0.030 0.683 ± 0.032 0.651 ± 0.031
24.960 ± 7.283c 27.492 ± 5.730d 34.028 ± 9.170c 37.156 ± 6.297c
EDE (300) 0.560 ± 0.037 0.730 ± 0.016 0.676 ± 0.037 0.651 ± 0.039 0.640 ± 0.026
37.307 ± 8.113abc 43.014 ± 12.271bc 55.269 ± 7.215ab 51.384 ± 8.623b
EDEW (300) 0.520 ± 0.046 0.705 ± 0.045 0.643 ± 0.030 0.633 ± 0.044 0.608 ± 0.039
31.752 ± 3.883bc 39.746 ± 10.125cd 44.648 ± 9.127bc 46.302 ± 8.975bc
EDM (300) 0.545 ± 0.032 0.738 ± 0.026 0.683 ± 0.031 0.676 ± 0.026 0.653 ± 0.039
28.665 ± 11.396c 32.394 ± 8.443cd 35.662 ± 12.938c 34.107 ± 8.975c
EDH E. dracunculoides n-hexane extract, EDA E. dracunculoides aqueous extract, EDE E. dracunculoides ethyl acetate, EDEW E. dracunculoides ethyl acetate + water
extract, EDM E. dracunculoides methanol extract (EDM), DIC diclofenac sodium
Data values shown represent mean ± SD (n = 6). Means with different superscript (a-d) letters in the column are significantly (P < 0.05) different from one another
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which defines that more active constituents exhibiting
inhibition of β-carotene bleaching belong to the TPC
while constituents having moderate activity are present
in TFC.
Hydroxyl radical is generated during various biochem-
ical reactions in the body. It is a short lived, very toxic
free radical having affinity for biomolecules like lipids,
proteins, amino acids, sugars, deoxyribonucleic acids,
leading to cancer, mutagenesis and cytotoxicity [44].
Superoxide dismutase converts superoxide radical into
hydrogen peroxide which is converted to a highly react-
ive hydroxyl radical. Evidence of •OH scavenging activity
by various extracts was obtained through deoxyribose
system [45]. In vivo hydroxyl radicals are probably pro-
duced through Haber–Weiss reaction where Fe+3 is re-
duced to Fe+2 with the help of O2
•- which leads to initiation
of Fenton reaction between H2O2 and Fe
+2 [46]. In the
present study EDEW and EDE extracts showed the best
activity with lower IC50 values. A significant correlation of
IC50 values was present with both TPC and TFC. Our
results are in well accordance to the findings of [47] who
reported methanol extract of Dicliptera roxburghiana as
the most active to scavenge hydroxyl radicals.
At pH 7.4 a vigorous generation of nitric oxide from
sodium nitroprusside occurs which further in favorable
conditions viz aerobic conditions and aqueous solution
react with oxygen and convert to nitrite ions, that can
be appraised by Griess reagent. These nitrite ions impart
pink color to the reaction mixture. Entities with NO−
scavenging abilities hinder the nitrite ion production by
consuming the available oxygen. In our study EDEW
and EDE showed comparatively good results than rest of
the extracts and significant correlation of IC50 values
was observed with TPC and TFC. This is due to the fact
that EDEW and EDE are rich in bioactive phenolic and
polyphenolics which have a fine tendency to scavenge
NO− free radicals that are responsible for oxidative
stress. Research of [48] and [49] is in agreement to our
findings.
Idea of iron chelating assay is based on the principle
of scavenger’s ability to decolorize the iron-ferrozine
complex. Ferrozine quickly reacts with the iron (II) to
form water soluble colored complex. Scavenging entity
present in the extract forms chelates with iron (II) hin-
dering the iron-ferrozine complex formation and ultim-
ately lowering the color intensity of the solution. In the
present study EDE exhibited the best performance with
lowest IC50 among all extracts in comparison to EDTA
used as standard. Significant correlation of IC50 values was
expressed with TFC (P < 0.01) and with TPC (P < 0.05) in-
dicating that more active flavonoids constituents for iron
chelation activity.
The basic principle of phosphomolybdate assay is that
antioxidant species reduces Mo (IV) to Mo (V) and this
reduced form of Mo forms complex with phosphate at
acidic pH and raised temperature impart dark green
color to the final solution [50]. The electron/ hydrogen
donating pattern of antioxidants depends upon its struc-
ture and series of redox reactions occurring in the activ-
ity [51]. EDEW and EDE showed admiring results than
that of EDM, EDA and EDH. The assay showed a good
correlation with TPC as well as TFC. Jan et al. [52] also
reported aqueous extract as the best extract in phospho-
molybdenum assay, followed by methanol. Moreover,
significant correlation has also been reported with TPC
which is in consensus with the present study but the
method of extraction was a bit different, which suggests
that this methodology made no difference in extracting
bioactive compounds responsible for total antioxidant
activity of the plant extract.
Reducing power of E. dracunculoides was determined
by using the potassium ferricynide reduction method. In
this assay iron (Fe+3) in ferric chloride is converted to
ferrous (Fe+2) by antioxidant compound/extract resulting
Table 8 Analgesic activity of E. dracunculoides of hot plate test in rat
Treatment
(mg/kg)
Latency time sec Percent analgesia
0 h 30 min 60 min 90 min 30 min 60 min 90 min
DMSO (2 ml) 9.000 ± 0.894 9.833 ± 1.169 10.167 ± 0.752 10.167 ± 0.752 3.971 ± 3.588d 5.490 ± 3.378e 5.490 ± 3.378e
Morphine (10) 9.333 ± 1.032 21.000 ± 1.549 25.667 ± 1.032 22.500 ± 1.048 56.160 ± 9.114b 78.889 ± 5.853a 63.632 ± 5.449ab
EDH (300) 9.833 ± 1.169 21.667 ± 1.633 24.833 ± 1.169 24.000 ± 1.095 58.304 ± 9.974a 74.309 ± 5.864b 70.206 ± 5.445a
EDA (300) 9.666 ± 0.816 14.167 ± 1.602 15.167 ± 1.169 16.833 ± 0.752 22.164 ± 6.680c 26.964 ± 6.193d 35.223 ± 3.210d
EDE (300) 10.000 ± 0.894 16.000 ± 1.414 22.333 ± 1.211 21.333 ± 1.032 29.804 ± 8.470bc 61.811 ± 4.528b 56.508 ± 6.363bc
EDEW (300) 9.666 ± 0.816 15.500 ± 1.048 19.333 ± 1.633 19.667 ± 1.032 28.676 ± 4.528bc 47.331 ± 9.410c 49.204 ± 4.254c
EDM (300) 9.666 ± 0.816 17.833 ± 1.472 20.000 ± 1.788 19.500 ± 1.048 40.196 ± 6.553b 50.959 ± 7.486bc 48.248 ± 5.943c
EDH E. dracunculoides n-hexane extract, EDA E. dracunculoides aqueous extract, EDE E. dracunculoides ethyl acetate, EDEW E. dracunculoides ethyl acetate + water
extract, EDM E. dracunculoides methanol extract
Data values shown represent mean ± SD (n = 6). Means with different superscript (a-e) letters in the column are significantly (P < 0.05) different from one another
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in conversion of yellow color of the test solution to
green. The intensity of green colour is directly propor-
tional to the reducing power of the sample. Basically re-
ducing power of the sample is due to hydrogen donating
ability of antioxidants to the free radicals [53]. The assay
was significantly correlated with TPC and TFC. This
assay results in a pattern of EDEW> EDE > EDM> EDA >
EDH at 250 μg/ml. Our study has been supported by the
report of [38] that crude methanol extract was the best
sample in reducing power assay after butanol.
Carrageenan is widely used to induce paw edema in
rodents to demonstrate anti-inflammatory effect of
drugs or herbs. Carrageenan-induced inflammation is
considered to be a biphasic model. Initial stage (1–2 h)
contributes to the release of histamine, bradykinin and
serotonin which mediates the increased synthesis of
prostaglandins from surrounding tissues of the injured
site. The later phase (3–4 h) is characterized by the ele-
vated level of prostaglandins mediated by the elevated
release of leukotrienes and bradykinin. During this phase
the cyclo-oxygenase-2 (COX-2) converts arachidonic
acid into prostaglandins which is a key factor of inflam-
mation maintenance. In this experiment carrageenan in-
duced edema in the hind paw of rats was inhibited by all
the extracts. EDH significantly inhibited the edema for-
mation; 1, 2, 3 and 4 h after the injection of carrageenan
in the hind paw of rats. These results indicated that the
phyto-constituents present in EDH inhibited the inflam-
matory mediators of the initial as well as late phase of
inflammation induced with carrageenan. The other ex-
tracts however, more effectively inhibited the edema
during the initial phase. Steroids are established anti-
inflammatory agents which inhibit the production of
prostaglandin not only by inducing the biosynthesis of
phospholipase A2 inhibitor but also by raising the level
of cyclo-oxygenase/PGE isomerase [54–56]. In the
present investigation GC-MS analysis of EDH revealed
the existence of stigmasta-5, 22-dien-3-ol, (3á,22E)-
(CAS); a phytosterol possesses strong anti-inflammatory
and analgesic properties probably contributing towards
the anti-inflammatory properties of EDH [57, 58]. The
standard drug also exhibited the strong anti-inflammatory
potential after 2, 3 and 4 h of carrageenan injection to rats.
Diclofenac sodium like other NSAIDs targets the COX-2
enzyme thereby inhibiting the formation of the paw
edema. The anti-inflammatory results obtained with EDH
in both phases might be attributed by the counteraction of
anti-inflammatory agents such as sterols and terpenoids
[59]. The anti-inflammatory effects obtained by the polar
extracts; EDE, EDA, EDEW and EDM during the initial
phase might be attributed by the presence of flavonoids
(rutin, catechin, caffeic acid and myricetin) and other con-
stituents. Anti-inflammatory activities of rutin, catechin
and caffeic acid have been well documented [60]. Our
studies are in consensus with [60] and [61, 62] who gener-
ated the same anti-inflammatory results of Acacia hydas-
pica and Boerhavia procumbens in rats.
Thermal nociception models such as, hot plate test
was used to evaluate the central analgesic activity. In this
study all the extracts of E. dracunculoides showed anal-
gesic effect in the hot plate test. EDH exhibited the best
potent analgesic activity among the extracts with 74.309
± 5.864 % inhibition of pain sensation followed by EDE
(61.811 ± 4.528 %) in comparison to morphine (78.889 ±
5.853 %) after 60 min of drug administration. Morphine
induces analgesic effect through activation of opioid re-
ceptors and the apparent similarity between the results
of extracts with standard morphine, indicates that they
might work in a same manner to reduce pain sensation.
The presence of steroids in EDH might induce the bio-
synthesis of phospholipase A2 inhibitor and cyclo-
oxygenase/PGE isomerase which in turn inhibits the
pain producing prostaglandins. Our results are in agree-
ments to the findings of Mondal et al. [63] evaluating
Alternanthera sessilis as analgesic agent. Backhouse et al.
[64] also reported the same results while evaluating Bud-
dleja globosa as analgesic and anti-inflammatory agent.
Conclusion
The present results suggest that the flavonoids in E.
dracunculoides might be the key players in scavenging of
oxidative stress inducing species while flavonoids along
with sterols and terpenoids alleviate the inflammation
and pain inducing mediators.
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